Is Incyte Stock Outperforming the Dow? [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
therapeutics for hematology/oncology, as well as inflammation and autoimmunity areas. Valued at $18.5 billion by market cap, the company follows the science to find solutions for patients with unmet medical needs. Companies worth $10 billion or more are generally described as “large-cap stocks,” and INCY perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the biotechnology industry. INCY has a strong portfolio of approved products. Its diverse pipeline in oncology and dermatology demonstrates a commitment to innovation and addressing unmet medical needs, providing multiple revenue streams and reducing dependency on a single product. More News from Barchart As Meta Stock Dips Near $600 Levels Should You Buy or Stay on the Sidelines? CoreWeave Stock Forecast: Buy, Sell, or Hold? SoFi Stock Is on Fire Sale, But Is It Too Cheap to Buy Here? Markets move fast. Keep up by reading our FREE midday Barchar
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Alnylam Pharmaceuticals (ALNY) had its "hold" rating reaffirmed by Jefferies Financial Group Inc.. They now have a $330.00 price target on the stock.MarketBeat
- Amvuttra (Medison Pharma, Alnylam Pharmaceuticals) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
- Tenaya Therapeutics (TNYA) Is Up 47.7% After Positive TN-301 DMD Data And Alnylam Deal [Yahoo! Finance]Yahoo! Finance
- Alnylam to Webcast TTR Investor Webinar [Yahoo! Finance]Yahoo! Finance
- Alnylam to Webcast TTR Investor WebinarBusiness Wire
ALNY
Earnings
- 2/12/26 - Beat
ALNY
Sec Filings
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- 3/6/26 - Form 4
- ALNY's page on the SEC website